On Feb 22nd, 6:30 PM Eastern/3:30 PM Pacific, GRACE and LUNGevity Foundation will be broadcasting a live panel discussion from Santa Monica, where the International Association for the Study of Lung Cancer will be kicking off its12th Annual Targeted Therapies of the Treatment of Lung Cancer Meeting. Host Dr. Jack West will be joined by four great luminaries from different centers of excellence and with different perspectives on the timely issue in lung cancer of molecular testing in advanced non-small cell lung cancer:
Over the course of an approximately 90 minute program, we’ll alternate between group discussions on a wide range of controversial questions in molecular testing and brief presentations by the panelists on key elements of this complex topic. The presentations planned are as follows:
Dr. Alice Shaw: Prevalence of mutations by histology, race, and smoking status
Dr. Charlie Rudin: Finding a druggable target: The Lung Cancer Mutation Consortium splintering lung cancer into small subsets
Dr. David Spigel: Integration of molecular markers into multicenter clinical trials: Benefits and Challenges
Dr. Glen Goss: The feasibility of integrating molecular markers across a comprehensive health care system: the intersection of benefit with cost and other practical factors










